Related references
Note: Only part of the references are listed.Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology
Chen Yang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Prognostic Effect of Inflammatory Genes on Stage I-III Colorectal Cancer-Integrative Analysis of TCGA Data
Eun Kyung Choe et al.
CANCERS (2021)
The Effects of Autophagy-Related Genes and lncRNAs in Therapy and Prognosis of Colorectal Cancer
Yang Yang et al.
FRONTIERS IN ONCOLOGY (2021)
SCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer
Hengyang Shen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Prognosis Prediction for Colorectal Cancer Patients: A Risk Score Based on The Metabolic-Related Genes
Yongqu Lu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Genome-wide somatic copy number alteration analysis and database construction for cervical cancer
Hong Luo et al.
MOLECULAR GENETICS AND GENOMICS (2020)
Metabolism-associated molecular classification of hepatocellular carcinoma
Chen Yang et al.
MOLECULAR ONCOLOGY (2020)
The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma
Jian Yang et al.
FRONTIERS IN ONCOLOGY (2020)
Health care provider and patient preparedness for alternative colorectal cancer follow-up; a review
S. M. Qaderi et al.
EJSO (2020)
Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients
Siqi Dai et al.
FRONTIERS IN GENETICS (2020)
A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis
Shuyuan Li et al.
FRONTIERS IN MEDICINE (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
Rui Huang et al.
BIOMARKER RESEARCH (2020)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7
Wu Di et al.
CELL DEATH & DISEASE (2019)
Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
Jie Xu et al.
CANCER RESEARCH (2019)
Inducible degradation of lncRNA Sros1 promotes IFN-γ-mediated activation of innate immune responses by stabilizing Stat1 mRNA
Henan Xu et al.
NATURE IMMUNOLOGY (2019)
Identification of a 6-gene signature predicting prognosis for colorectal cancer
Shuguang Zuo et al.
CANCER CELL INTERNATIONAL (2019)
Contribution of Angiogenesis to Inflammation and Cancer
Dolores Aguilar-Cazares et al.
FRONTIERS IN ONCOLOGY (2019)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Long noncoding RNA VIM-AS1 promotes colorectal cancer progression and metastasis by inducing EMT
Hajar Rezanejad Bardaji et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors
Matthew Frampton et al.
GENETICS IN MEDICINE (2017)
EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez-Carmona et al.
MOLECULAR ONCOLOGY (2017)
Inflammation and Colorectal Cancer
Apple G. Long et al.
CURRENT COLORECTAL CANCER REPORTS (2017)
Inflammation as a driver and vulnerability of KRAS mediated oncogenesis
Shunsuke Kitajima et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases
Ferenc Sipos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Biostatistics Series Module 3: Comparing Groups: Numerical Variables
Avijit Hazra et al.
INDIAN JOURNAL OF DERMATOLOGY (2016)
Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk A Population-Based, Case-Control Study
Soren Friis et al.
ANNALS OF INTERNAL MEDICINE (2015)
Essential Role for Oxidative Phosphorylation in Cancer Progression
Maria Chiara Maiuri et al.
CELL METABOLISM (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Fibroblast Growth Factor Receptor 1 Gene Copy Number and mRNA Expression in Primary Colorectal Cancer and Its Clinicopathologic Correlation
Yoonjin Kwak et al.
PATHOBIOLOGY (2015)
Colorectal cancer
Ernst J. Kuipers et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Gene: a gene-centered information resource at NCBI
Garth R. Brown et al.
NUCLEIC ACIDS RESEARCH (2015)
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
Paul Geeleher et al.
PLOS ONE (2014)
Fibroblast Growth Factor Receptor 1 as a Putative Therapy Target in Colorectal Cancer
Friederike Goeke et al.
DIGESTION (2013)
Hypoxia-inducible factors as key regulators of tumor inflammation
Soulafa Mamlouk et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
Paul R. Gavine et al.
CANCER RESEARCH (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models
Ezia Bello et al.
CANCER RESEARCH (2011)
Epithelial cell polarity: a major gatekeeper against cancer?
C. Royer et al.
CELL DEATH AND DIFFERENTIATION (2011)
Deciphering tumor-suppressor signaling in flies: Genetic link between Scribble/Dlg/Lgl and the Hippo pathways
Masato Enomoto et al.
JOURNAL OF GENETICS AND GENOMICS (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Massimo Ammirante et al.
NATURE (2010)
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Rajnish A. Gupta et al.
NATURE (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials
Daniel Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma
K. Zen et al.
ONCOGENE (2009)
Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis:: Potential role of chronic inflammation
Kan Yang et al.
CANCER RESEARCH (2008)
Microtubule Active Agents: Beyond the Taxane Frontier
Patrick G. Morris et al.
CLINICAL CANCER RESEARCH (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Novel inhibitor for fibroblast growth factor receptor tyrosine kinase
Naparat Kammasuda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist
Mark Ayers et al.
CANCER RESEARCH (2007)
Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs
John L. Rinn et al.
CELL (2007)
Follow-up strategies for patients treated for non-metastatic colorectal cancer
M. Jeffery et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation
Jean-Jacques Briere et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Tsix-mediated epigenetic switch of a CTCF-flanked region of the Xist promoter determines the Xist transcription program
Pablo Navarro et al.
GENES & DEVELOPMENT (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Reciprocal relationship in gene expression between FGFR1 and FGFR3:: implication for tumorigenesis
JH Jang
ONCOGENE (2005)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
